HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombin-induced platelet factor Va formation in patients with a gray platelet syndrome.

Abstract
The present study was initiated to establish the functional factor V concentration in platelets of patients with a mild bleeding disorder ascribed to a gray platelet syndrome. This inherited platelet disorder has been characterized by a specific deficiency of alpha-granules and subsequent deficiencies in the alpha-granule proteins. We found that the concentration of plasma factor V was slightly decreased (70% of normal values). In contrast, platelet factor Va formation was severely impaired. Besides a much lower factor V content than in control platelets (10-20% of normal), the dependency of platelet factor Va formation on thrombin concentration was altered. Increasing the thrombin concentration 4-fold compared to the concentration that results in maximal factor Va generation from normal platelets did not result in a maximal factor Va formation from gray platelets. When a suspension of washed gray platelets was incubated with a prostacyclin analogue prior to the stimulation with thrombin, a 10-fold lower factor Va activity was measured. Thus, thrombin-induced factor Va formation in a suspension of gray platelets is the result of a release reaction, followed by the thrombin-catalyzed activation of released factor V. Whereas the kinetics of the former reaction are apparently impaired, the kinetics of the latter one were found to be identical to those observed for normal platelet and plasma factor V activation.
AuthorsD Baruch, T Lindhout, E Dupuy, J P Caen
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 58 Issue 2 Pg. 768-71 (Aug 04 1987) ISSN: 0340-6245 [Print] Germany
PMID2445043 (Publication Type: Journal Article)
Chemical References
  • Factor Va
  • Factor V
  • Epoprostenol
  • Thrombin
  • Iloprost
Topics
  • Blood Platelet Disorders (blood)
  • Blood Platelets (drug effects, metabolism)
  • Epoprostenol (pharmacology)
  • Factor V (biosynthesis)
  • Factor Va
  • Humans
  • Iloprost
  • In Vitro Techniques
  • Syndrome
  • Thrombin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: